Amifostine for Head and Neck Irradiation in Lymphoma

Clinical trial NCT00136474 · COMPLETED

Trial details

NCT number: NCT00136474
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma Hodgkin's Disease Non-Hodgkin's Lymphoma

Start date: 2003-05-01
Primary completion: 2005-05-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.